BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 15193446)

  • 21. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
    Ibrahim S; Jilani I; O'Brien S; Rogers A; Manshouri T; Giles F; Faderl S; Thomas D; Kantarjian H; Keating M; Albitar M
    Cancer; 2003 Apr; 97(8):1914-9. PubMed ID: 12673718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia.
    Bentz M; Plesch A; Bullinger L; Stilgenbauer S; Ott G; Müller-Hermelink HK; Baudis M; Barth TF; Möller P; Lichter P; Döhner H
    Genes Chromosomes Cancer; 2000 Mar; 27(3):285-94. PubMed ID: 10679918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
    Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic and immunophenotypic profile of IGH@ rearrangement detected by fluorescence in situ hybridization in 149 cases of B-cell chronic lymphocytic leukemia.
    Lu G; Kong Y; Yue C
    Cancer Genet Cytogenet; 2010 Jan; 196(1):56-63. PubMed ID: 19963136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translocation t(X;11)(q13;q23) in B-cell chronic lymphocytic leukemia disrupts two novel genes.
    Kalla C; Nentwich H; Schlotter M; Mertens D; Wildenberger K; Döhner H; Stilgenbauer S; Lichter P
    Genes Chromosomes Cancer; 2005 Feb; 42(2):128-43. PubMed ID: 15543602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chromosome study on chronic lymphocytic leukemia using CpG-oligodeoxynucleotide as immunostimulant agent].
    Wu Y; Xue Y; Chen S; Yao L; Jiang H; Zhang J; Shen J; Pan J; Wang Y; Bai S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):86-91. PubMed ID: 20140876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia.
    Schaffner C; Stilgenbauer S; Rappold GA; Döhner H; Lichter P
    Blood; 1999 Jul; 94(2):748-53. PubMed ID: 10397742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis.
    Cuneo A; Rigolin GM; Bigoni R; De Angeli C; Veronese A; Cavazzini F; Bardi A; Roberti MG; Tammiso E; Agostini P; Ciccone M; Della Porta M; Tieghi A; Cavazzini L; Negrini M; Castoldi G
    Leukemia; 2004 Mar; 18(3):476-83. PubMed ID: 14712287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deletions at 11q23 in different lymphoma subtypes.
    Zhu Y; Monni O; Franssila K; Elonen E; Vilpo J; Joensuu H; Knuutila S
    Haematologica; 2000 Sep; 85(9):908-12. PubMed ID: 10980627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
    Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Ribatti D; Digiesi G
    Eur J Haematol; 2004 Jul; 73(1):36-42. PubMed ID: 15182336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overlapping deletion regions at 11q23 in myelodysplastic syndrome and chronic lymphocytic leukemia, characterized by a novel BAC probe set.
    Siew-Gek Lee A; Rudduck-Sivaswaren C; Khun-Hong Lie D; Li-Ming Chua C; Tien SL; Morsberger L; Griffin CA
    Cancer Genet Cytogenet; 2004 Sep; 153(2):151-7. PubMed ID: 15350305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unique gene expression and clinical characteristics are associated with the 11q23 deletion in chronic lymphocytic leukaemia.
    Dickinson JD; Smith LM; Sanger WG; Zhou G; Townley P; Lynch JC; Pavletic ZS; Bierman PJ; Joshi SS
    Br J Haematol; 2005 Feb; 128(4):460-71. PubMed ID: 15686453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization to detect chromosomal abnormalities in chronic lymphocytic leukemia: a comparative study.
    Fabris S; Scarciolla O; Morabito F; Cifarelli RA; Dininno C; Cutrona G; Matis S; Recchia AG; Gentile M; Ciceri G; Ferrarini M; Ciancio A; Mannarella C; Neri A; Fragasso A
    Genes Chromosomes Cancer; 2011 Sep; 50(9):726-34. PubMed ID: 21638517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of chromosomal abnormalities associated with chronic lymphocytic leukemia: what is the best method?
    El-Taweel M; Barin C; Cymbalista F; Eclache V
    Cancer Genet Cytogenet; 2009 Nov; 195(1):37-42. PubMed ID: 19837267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological and clinical characterization of recurrent 14q deletions in CLL and other mature B-cell neoplasms.
    Reindl L; Bacher U; Dicker F; Alpermann T; Kern W; Schnittger S; Haferlach T; Haferlach C
    Br J Haematol; 2010 Oct; 151(1):25-36. PubMed ID: 20649559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
    Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS
    Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation.
    Cuneo A; Bigoni R; Negrini M; Bullrich F; Veronese ML; Roberti MG; Bardi A; Rigolin GM; Cavazzini P; Croce CM; Castoldi G
    Cancer Res; 1997 Mar; 57(6):1144-50. PubMed ID: 9067285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of chromosomal anomalies detected with FISH and their clinical correlations in B-chronic lymphocytic leukemia.
    Sindelárová L; Michalová K; Zemanová Z; Ransdorfová S; Brezinová J; Peková S; Schwarz J; Karban J; Cmunt E
    Cancer Genet Cytogenet; 2005 Jul; 160(1):27-34. PubMed ID: 15949567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of 11q22-q23 deletion target genes in B-cell chronic lymphocytic leukaemia: evidence for a pathogenic role of NPAT, CUL5, and PPP2R1B.
    Kalla C; Scheuermann MO; Kube I; Schlotter M; Mertens D; Döhner H; Stilgenbauer S; Lichter P
    Eur J Cancer; 2007 May; 43(8):1328-35. PubMed ID: 17449237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The study of different chromosomal aberrations, CD38 and ZAP-70 in chronic lymphocytic leukemia patients.
    Hassab AH; Elbordiny MM; Elghandour AH; Sorour AF; Swelem RS
    Egypt J Immunol; 2011; 18(2):77-93. PubMed ID: 23082473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.